Scinai Immunotherapeutics annual net debt
2020
2021
2022
2023
2024
2025
Scinai Immunotherapeutics Net Debt Growth & History (SCNI)
Scinai Immunotherapeutics's net debt was $300,000 for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $300,000 | $438,000 | — |
| 2024 | 2024-12-31 | −$138,000 | $3.5M | — |
| 2023 | 2023-12-31 | −$3.7M | $9.6M | — |
| 2022 | 2022-12-31 | −$13.3M | −$5.4M | — |
| 2021 | 2021-12-31 | −$7.9M | −$6.8M | — |
| 2020 | 2020-12-31 | −$1.1M | — | — |
Scinai Immunotherapeutics quarterly net debt
Q4.20
Q3.21
Q4.21
Q2.22
Q4.22
Q1.23
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $926,000 | −$198,000 | −17.62% |
| Q1 2026 | 2026-03-31 | $533,000 | — | — |
| Q4 2025 | 2025-12-31 | $300,000 | $438,000 | — |
| Q2 2025 | 2025-06-30 | $1.1M | $3.2M | — |
| Q4 2024 | 2024-12-31 | −$138,000 | $3.5M | — |
| Q2 2024 | 2024-06-30 | −$2.1M | $4.1M | — |
| Q4 2023 | 2023-12-31 | −$3.7M | $9.6M | — |
| Q2 2023 | 2023-06-30 | −$6.2M | $3.5M | — |
| Q1 2023 | 2023-03-31 | −$10.4M | — | — |
| Q4 2022 | 2022-12-31 | −$13.3M | −$5.4M | — |
| Q2 2022 | 2022-06-30 | −$9.7M | — | — |
| Q4 2021 | 2021-12-31 | −$7.9M | −$6.8M | — |
| Q3 2021 | 2021-09-30 | −$8.9M | — | — |
| Q4 2020 | 2020-12-31 | −$1.1M | — | — |
Scinai Immunotherapeutics net debt trends
Over the last five fiscal years, Scinai Immunotherapeutics's net debt increased from −$1.1M to $300,000, a change of $1.4M. The latest reported quarter, Q2 2026, shows $926,000.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗